Biosimilar Contract Manufacturing Market Size, Share, Growth, and Industry Analysis, By Types (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins, ), By Applications (Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic & Autoimmune Disorders, Rheumatoid Arthritis, Others, ) , and Regional Insights and Forecast to 2035

Table of Content



1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Biosimilar Contract Manufacturing Market Size

1.3 Market Segmentation

1.4 Regulatory Environment



2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Biosimilar Contract Manufacturing Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Biosimilar Contract Manufacturing Business Mode and Production Process

2.3.1 Biosimilar Contract Manufacturing Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Biosimilar Contract Manufacturing Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Biosimilar Contract Manufacturing

2.4.2 Raw Material Cost of Biosimilar Contract Manufacturing

2.4.3 Labor Cost of Biosimilar Contract Manufacturing

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis



3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War



4 Market Competitive Landscape

4.1 Global Biosimilar Contract Manufacturing Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Biosimilar Contract Manufacturing Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Biosimilar Contract Manufacturing Price by Manufacturer (2021-2026)

4.4 Biosimilar Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Biosimilar Contract Manufacturing, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Biosimilar Contract Manufacturing, Product Offered and Application

4.7 Biosimilar Contract Manufacturing Market Competitive Situation and Trends

4.7.1 Biosimilar Contract Manufacturing Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Biosimilar Contract Manufacturing Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans



5 Global Biosimilar Contract Manufacturing Market Historical Development by Geographic Region (2021-2026)

5.1 Global Biosimilar Contract Manufacturing Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Biosimilar Contract Manufacturing Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Biosimilar Contract Manufacturing Market Status by Country (2021-2026)

5.3.1 North America Biosimilar Contract Manufacturing Sales Volume by Country (2021-2026)

5.3.2 North America Biosimilar Contract Manufacturing Revenue by Country (2021-2026)

5.3.3 United States Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Biosimilar Contract Manufacturing Market Status by Country (2021-2026)

5.4.1 Europe Biosimilar Contract Manufacturing Sales Volume by Country (2021-2026)

5.4.2 Europe Biosimilar Contract Manufacturing Revenue by Country (2021-2026)

5.4.3 Germany Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Biosimilar Contract Manufacturing Market Status by Country (2021-2026)

5.5.1 Asia Pacific Biosimilar Contract Manufacturing Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Biosimilar Contract Manufacturing Revenue by Country (2021-2026)

5.5.3 China Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Biosimilar Contract Manufacturing Market Status by Country (2021-2026)

5.6.1 Latin America Biosimilar Contract Manufacturing Sales Volume by Country (2021-2026)

5.6.2 Latin America Biosimilar Contract Manufacturing Revenue by Country (2021-2026)

5.6.3 Mexico Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Biosimilar Contract Manufacturing Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Biosimilar Contract Manufacturing Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Biosimilar Contract Manufacturing Revenue by Country (2021-2026)

5.7.3 GCC Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Biosimilar Contract Manufacturing Sales Volume, Revenue and Growth (2021-2026)



6 Global Biosimilar Contract Manufacturing Market Historical Development by Product Type (2021-2026)

6.1 Biosimilar Contract Manufacturing Definition by Type

6.2 Global Biosimilar Contract Manufacturing Historical Sales Volume by Product Type (2021-2026)

6.3 Global Biosimilar Contract Manufacturing Historical Revenue by Product Type (2021-2026)

6.4 Global Biosimilar Contract Manufacturing Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Recombinant Non-glycosylated Proteins (2021-2026)
6.5.2 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Recombinant Glycosylated Proteins (2021-2026)


7 Global Biosimilar Contract Manufacturing Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Biosimilar Contract Manufacturing Historical Sales Volume by End User (2021-2026)

7.3 Global Biosimilar Contract Manufacturing Historical Revenue by End User (2021-2026)

7.4 Global Biosimilar Contract Manufacturing Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Oncology (2021-2026)
7.5.2 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Blood Disorders (2021-2026)
7.5.3 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Growth Hormonal Deficiency (2021-2026)
7.5.4 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Chronic & Autoimmune Disorders (2021-2026)
7.5.5 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Rheumatoid Arthritis (2021-2026)
7.5.6 Global Biosimilar Contract Manufacturing Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)


8 Leading Companies Profiles

8.1 Fujifilm Kyowa Kirin Biologics Co., Ltd.
8.1.1 Fujifilm Kyowa Kirin Biologics Co., Ltd. Corporation Information
8.1.2 Fujifilm Kyowa Kirin Biologics Co., Ltd. - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.1.3 Fujifilm Kyowa Kirin Biologics Co., Ltd. Performance Analysis (2021-2026)
8.1.4 Fujifilm Kyowa Kirin Biologics Co., Ltd. Business and Markets Served
8.1.5 Fujifilm Kyowa Kirin Biologics Co., Ltd. Recent Developments
8.2 Almac Group
8.2.1 Almac Group Corporation Information
8.2.2 Almac Group - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.2.3 Almac Group Performance Analysis (2021-2026)
8.2.4 Almac Group Business and Markets Served
8.2.5 Almac Group Recent Developments
8.3 IQVIA Inc.
8.3.1 IQVIA Inc. Corporation Information
8.3.2 IQVIA Inc. - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.3.3 IQVIA Inc. Performance Analysis (2021-2026)
8.3.4 IQVIA Inc. Business and Markets Served
8.3.5 IQVIA Inc. Recent Developments
8.4 Thermo Fisher Scientific Inc.
8.4.1 Thermo Fisher Scientific Inc. Corporation Information
8.4.2 Thermo Fisher Scientific Inc. - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.4.3 Thermo Fisher Scientific Inc. Performance Analysis (2021-2026)
8.4.4 Thermo Fisher Scientific Inc. Business and Markets Served
8.4.5 Thermo Fisher Scientific Inc. Recent Developments
8.5 Alcami Corporation, Inc.
8.5.1 Alcami Corporation, Inc. Corporation Information
8.5.2 Alcami Corporation, Inc. - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.5.3 Alcami Corporation, Inc. Performance Analysis (2021-2026)
8.5.4 Alcami Corporation, Inc. Business and Markets Served
8.5.5 Alcami Corporation, Inc. Recent Developments
8.6 Boehringer Ingelheim Biopharmaceuticals GmbH
8.6.1 Boehringer Ingelheim Biopharmaceuticals GmbH Corporation Information
8.6.2 Boehringer Ingelheim Biopharmaceuticals GmbH - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.6.3 Boehringer Ingelheim Biopharmaceuticals GmbH Performance Analysis (2021-2026)
8.6.4 Boehringer Ingelheim Biopharmaceuticals GmbH Business and Markets Served
8.6.5 Boehringer Ingelheim Biopharmaceuticals GmbH Recent Developments
8.7 Samsung Biologics
8.7.1 Samsung Biologics Corporation Information
8.7.2 Samsung Biologics - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.7.3 Samsung Biologics Performance Analysis (2021-2026)
8.7.4 Samsung Biologics Business and Markets Served
8.7.5 Samsung Biologics Recent Developments
8.8 Avid Bioservices, Inc.
8.8.1 Avid Bioservices, Inc. Corporation Information
8.8.2 Avid Bioservices, Inc. - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.8.3 Avid Bioservices, Inc. Performance Analysis (2021-2026)
8.8.4 Avid Bioservices, Inc. Business and Markets Served
8.8.5 Avid Bioservices, Inc. Recent Developments
8.9 Rentschler Biopharma SE
8.9.1 Rentschler Biopharma SE Corporation Information
8.9.2 Rentschler Biopharma SE - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.9.3 Rentschler Biopharma SE Performance Analysis (2021-2026)
8.9.4 Rentschler Biopharma SE Business and Markets Served
8.9.5 Rentschler Biopharma SE Recent Developments
8.10 Lonza
8.10.1 Lonza Corporation Information
8.10.2 Lonza - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.10.3 Lonza Performance Analysis (2021-2026)
8.10.4 Lonza Business and Markets Served
8.10.5 Lonza Recent Developments
8.11 WuXi Biologics
8.11.1 WuXi Biologics Corporation Information
8.11.2 WuXi Biologics - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.11.3 WuXi Biologics Performance Analysis (2021-2026)
8.11.4 WuXi Biologics Business and Markets Served
8.11.5 WuXi Biologics Recent Developments
8.12 Catalent, Inc.
8.12.1 Catalent, Inc. Corporation Information
8.12.2 Catalent, Inc. - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.12.3 Catalent, Inc. Performance Analysis (2021-2026)
8.12.4 Catalent, Inc. Business and Markets Served
8.12.5 Catalent, Inc. Recent Developments
8.13 AGC Biologics
8.13.1 AGC Biologics Corporation Information
8.13.2 AGC Biologics - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.13.3 AGC Biologics Performance Analysis (2021-2026)
8.13.4 AGC Biologics Business and Markets Served
8.13.5 AGC Biologics Recent Developments
8.14 Element Materials Technology
8.14.1 Element Materials Technology Corporation Information
8.14.2 Element Materials Technology - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.14.3 Element Materials Technology Performance Analysis (2021-2026)
8.14.4 Element Materials Technology Business and Markets Served
8.14.5 Element Materials Technology Recent Developments
8.15 Biocon
8.15.1 Biocon Corporation Information
8.15.2 Biocon - Biosimilar Contract Manufacturing Product Portfolio and Specification
8.15.3 Biocon Performance Analysis (2021-2026)
8.15.4 Biocon Business and Markets Served
8.15.5 Biocon Recent Developments


9 Global Biosimilar Contract Manufacturing Market Forecast by Product Type and End User (2026-2034)

9.1 Global Biosimilar Contract Manufacturing Market Forecast by Product Type (2026-2034)

9.1.1 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Recombinant Non-glycosylated Proteins (2026-2034)
9.1.2 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Recombinant Glycosylated Proteins (2026-2034)
9.2 Global Biosimilar Contract Manufacturing Market Forecast by End User (2026-2034)

9.2.1 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Oncology (2026-2034)
9.2.2 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Blood Disorders (2026-2034)
9.2.3 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Growth Hormonal Deficiency (2026-2034)
9.2.4 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Chronic & Autoimmune Disorders (2026-2034)
9.2.5 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Rheumatoid Arthritis (2026-2034)
9.2.6 Global Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)


10 Global Biosimilar Contract Manufacturing Market Forecast by Geographic Region (2026-2034)

10.1 Global Biosimilar Contract Manufacturing Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Biosimilar Contract Manufacturing Sales Volume, Revenue Forecast and Growth (2026-2034)



11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer